Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods. The aim of this study was to investigate whether candidate polymorphisms in five genes (ADAM10, BACE1, BACE2, PSEN2, and CLU) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results. We found an association of rs638405 in BACE1 with increased risk of PD, thus provi...
The β site APP cleaving enzyme 1 (BACE1) is the rate-limiting β-secretase enzyme in the amyloidogeni...
Rare mutations in AβPP, PSEN1, and PSEN2 cause uncommon early onset forms of Alzheimer's disease (AD...
With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic ...
Background. Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, inclu...
This is an open access article distributed under the Creative Commons Attribution License, which pe...
Copyright © 2015 Johannes Lange et al.This is an open access article distributed under the Creative ...
Alzheimer disease (AD) is characterized neuropathologically by neurofibrillary tangles and senile pl...
Alzheimer disease (AD) is characterized neuropathologically by neurofibrillary tangles and senile pl...
AbstractGenetic susceptibility, is considered to be involved in neurodegenerative diseases such as A...
The BACE1 gene encodes the beta-site APP-cleaving enzyme 1 and has been associated with Alzheimer's ...
Abstract The BACE1 gene encodes the beta-site APP-cleaving enzyme 1 and has been associated with Alz...
Many individuals with Parkinson's disease (PD) develop cognitive deficits, and a phenotypic and mole...
Many individuals with Parkinson's disease (PD) develop cognitive deficits, and a phenotypic and ...
Dissecting the genetics of Alzheimer’s disease (AD) and Parkinson’s disease (PD) has contributed si...
Cleavage of the amyloid precursor protein (APP) occurs through either an amyloidogenic or a non-amyl...
The β site APP cleaving enzyme 1 (BACE1) is the rate-limiting β-secretase enzyme in the amyloidogeni...
Rare mutations in AβPP, PSEN1, and PSEN2 cause uncommon early onset forms of Alzheimer's disease (AD...
With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic ...
Background. Parkinson’s disease (PD) and Alzheimer’s disease (AD) share pathological features, inclu...
This is an open access article distributed under the Creative Commons Attribution License, which pe...
Copyright © 2015 Johannes Lange et al.This is an open access article distributed under the Creative ...
Alzheimer disease (AD) is characterized neuropathologically by neurofibrillary tangles and senile pl...
Alzheimer disease (AD) is characterized neuropathologically by neurofibrillary tangles and senile pl...
AbstractGenetic susceptibility, is considered to be involved in neurodegenerative diseases such as A...
The BACE1 gene encodes the beta-site APP-cleaving enzyme 1 and has been associated with Alzheimer's ...
Abstract The BACE1 gene encodes the beta-site APP-cleaving enzyme 1 and has been associated with Alz...
Many individuals with Parkinson's disease (PD) develop cognitive deficits, and a phenotypic and mole...
Many individuals with Parkinson's disease (PD) develop cognitive deficits, and a phenotypic and ...
Dissecting the genetics of Alzheimer’s disease (AD) and Parkinson’s disease (PD) has contributed si...
Cleavage of the amyloid precursor protein (APP) occurs through either an amyloidogenic or a non-amyl...
The β site APP cleaving enzyme 1 (BACE1) is the rate-limiting β-secretase enzyme in the amyloidogeni...
Rare mutations in AβPP, PSEN1, and PSEN2 cause uncommon early onset forms of Alzheimer's disease (AD...
With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic ...